Oxford Gene Technology, A Sysmex Group Company, has developed a breakthrough targeted NGS panel for constitutional cytogenetics research. The new CytoSure NGS panel—launching early in 2020 ...

The Global Cytogenetics Market is estimated to be valued at approximately USD 2.42 billion in 2023 and is expected to grow at a robust CAGR of 9.5% over the forecast period 2024-2032. Request To ...

Today, banding techniques such as Giemsa-trypsin based staining are commonly used in diagnostic cytogenetics, and they can provide a resolution greater than 5 Mb. In addition, more sophisticated ...

Since then, researchers have developed a variety of other chromosome banding techniques that have largely supplanted Q-banding in clinical cytogenetics. Today, most karyotypes are stained with ...

A recent study evaluates the dosing, safety, and efficacy of telaglenastat and azacytidine to treat advanced myelodysplastic ...

A recent study released by researchers at North Carolina State University offers new insights and guidelines for the accurate ...

BUFFALO, NY- October 11, 2024 – A new editorial was published in Oncotarget's Volume 15 on October 1, 2024, entitled, ...

A new editorial was published in Oncotarget's Volume 15 on October 1, 2024, entitled, "Transplant or no transplant for TP53 ...

India’s diagnostics sector, valued at $15 billion, is experiencing rapid growth, yet remains fragmented with over 100,000 ...

Ciltacabtagene autoleucel (cilta-cel) CAR T-cell therapy for relapsed/refractory multiple myeloma (RRMM) results in a deep ...

RIO DE JANEIRO — A quadruplet induction regimen of isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in the ...

Manipal HealthMap acquires iGenetic Diagnostics to expand services in key markets, aiming for nationwide growth and ...